Align Technology, Inc.: Align Technology Prevails in China Patent Infringement Action Against Angelalign
Align Technology (Nasdaq: ALGN) said China’s Jinan Intermediate People’s Court ruled in its favor in a patent infringement case against Angelalign’s China subsidiaries. The court found Angel infringed Align’s CN113693748B patent tied to extraction-gap-closure technology, ordering a stop to use and sales in China and awarding RMB 10 million in damages. Angel can appeal.
How this was made
The 30-second read
Why it matters
The court’s cease-use and cease-manufacture/sales order, plus damages, strengthens Align’s IP position in China, but appeal timing and potential reversal remain key swing factors.
Market read
This is a concrete, first-instance China IP enforcement win for Align, adding to an ongoing multi-forum litigation campaign against Angel.
What to watch
The article does not state whether Angel’s infringing products represent a large share of Angel’s China revenue, nor does it provide expected enforcement duration or likelihood of reversal on appeal.
Background
Align previously filed patent infringement actions against Angel in China and has also pursued enforcement via UPC and the US ITC.
Ticker impact
Align won a China patent infringement case, with the court ordering Angel to stop using the technology and awarding RMB 10 million damages.
Mildly positive bias for ALGN, with upside capped by the possibility of appeal and the relatively modest stated damages.
The article discloses a specific first-instance judgment, injunction to cease infringement, and damages, but also notes the ruling is appealable and does not quantify broader revenue impact.
Market effects
Reinforces that clear aligner digital workflow IP can be enforced in China, potentially supporting pricing power and competitive moat narratives for digital orthodontics.
Positive signal for US-listed medtech with China manufacturing and litigation exposure; may influence how investors price China IP risk.
Adds to a multi-jurisdiction enforcement track (UPC, ITC, China), which can affect global competitive dynamics and settlement leverage.
Counterpoint
Because the judgment is subject to appeal and the damages are limited (RMB 10 million), the market may discount the financial impact and focus on timing of final resolution.
Key entities
- public_companyAlign Technology, Inc.
US-listed clear aligner and digital orthodontics company that won a first-instance China patent infringement judgment.
- private_or_otherAngelalign Technology (Angel)
Defendant operating subsidiaries in China accused of infringing Align patents related to extraction-gap-closure technology.
- courtJinan Intermediate People’s Court
Chinese court that issued the first-instance judgment in Align’s favor.
- regulatorU.S. International Trade Commission (ITC)
Forum where Align is pursuing additional patent claims against Angel, with an initial determination expected in November 2026.
